The SCALE (Satiety and Clinical AdiposityLiraglutide Evidence) study comprised a series of Phase 3 trials evaluating the efficacy of Liraglutide 3 mg in diverse populations, including general obese patients, as well as those with pre-diabetes, diabetes, and sleep apnea syndrome 10,11,12,13,14,15
doi:10.1016/j.pcad.2023.02.005 Lloyd-Jones DM, Allen NB, Anderson CAM, et al
Boosts melanin Raises the enzyme responsible for producing skin-darkening pigment
As with any medical treatment, Dr
GLP-1 medications affect gastric motility, and some people experience nausea, changes in bowel habits, or other GI symptoms during treatment particularly in the early months
In liver tissue, GLP-1 levels are considered to be highest in human organs [31]